Related references
Note: Only part of the references are listed.Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus
Selcan Demir et al.
RHEUMATOLOGY (2021)
Accrual of Atherosclerotic Vascular Events in a Multicenter Inception Systemic Lupus Erythematosus Cohort
Murray B. Urowitz et al.
ARTHRITIS & RHEUMATOLOGY (2020)
The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
M. Frodlund et al.
LUPUS (2019)
Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression
Anselm Mak et al.
SCIENTIFIC REPORTS (2017)
Stroke in systemic lupus erythematosus: a Swedish population-based cohort study
Elizabeth V. Arkema et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Venous and Arterial Thrombotic Events in Systemic Lupus Erythematosus
Andrea Hinojosa-Azaola et al.
JOURNAL OF RHEUMATOLOGY (2016)
Dyslipidemia in systemic lupus erythematosus: just another comorbidity?
Konstantinos Tselios et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Mortality in Systemic Lupus Erythematosus: an Updated Review
Cesar E. Fors Nieves et al.
CURRENT RHEUMATOLOGY REPORTS (2016)
Systemic lupus erythematosus and thrombosis
Mario Bazzan et al.
THROMBOSIS JOURNAL (2015)
Systemic lupus erythematosus
Larissa Lisnevskaia et al.
LANCET (2014)
Inhibition of Renin Angiotensin Axis May Be Associated with Reduced Risk of Developing Venous Thromboembolism in Patients with Atherosclerotic Disease
Young Kwang Chae et al.
PLOS ONE (2014)
Lupus disease activity and the risk of subsequent organ damage and mortality in a large lupus cohort
Rekha Lopez et al.
RHEUMATOLOGY (2012)
Glucocorticoid use and abuse in SLE
Guillermo Ruiz-Irastorza et al.
RHEUMATOLOGY (2012)
American College of Rheumatology classification criteria for Sjogren's syndrome: A data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance Cohort
S. C. Shiboski et al.
ARTHRITIS CARE & RESEARCH (2012)
Prevalence of and Factors Associated with Hypertension in Young and Old Women with Systemic Lupus Erythematosus
Jose Mario Sabio et al.
JOURNAL OF RHEUMATOLOGY (2011)
Reinventing the ACE inhibitors: some old and new implications of ACE inhibition
Kashif Hanif et al.
HYPERTENSION RESEARCH (2010)
Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII)
Paula I. Burgos et al.
RHEUMATOLOGY (2010)
The Role of Renin-Angiotensin System in Prothrombotic State in Essential Hypertension
A. Remkova et al.
PHYSIOLOGICAL RESEARCH (2010)
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Determinants of Risk for Venous and Arterial Thrombosis in Primary Antiphospholipid Syndrome and in Antiphospholipid Syndrome with Systemic Lupus Erythematosus
Adriana Danowski et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mortality in systemic lupus erythematosus
S. Bernatsky et al.
ARTHRITIS AND RHEUMATISM (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Incidence and risk factors of thromboembolism in systemic lupus erythematosus - A comparison of three ethnic groups
CC Mok et al.
ARTHRITIS AND RHEUMATISM (2005)
Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus
ZS Sarabi et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women - Life course analysis
OH Franco et al.
HYPERTENSION (2005)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
MJ Roman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus
A Doria et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
The epidemiology of venous thromboembolism
RH White
CIRCULATION (2003)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Mortality and causes of death in systemic lupus erythematosus
J Trager et al.
CURRENT OPINION IN RHEUMATOLOGY (2001)
Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies -: Do the benefits outweigh the risks?: A decision analysis
DG Wahl et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
